The aim of this study was to assess the current evidence for long-acting β2-agonist (LABA)/long-acting muscarinic antagonist (LAMA) fixed-dose combinations (FDCs) in the treatment of COPD
Objectives: To assess the current evidence for long-acting β2-agonist (LABA)/long-acting muscarinic ...
Objectives: To assess the current evidence for long-acting β2-agonist (LABA)/long-acting muscarinic ...
Objectives: The aim of this study was to assess the current evidence for long-acting \u3922-agonist ...
The aim of this study was to assess the current evidence for long-acting β2-agonist (LABA)/long-acti...
The aim of this study was to assess the current evidence for long-acting β2-agonist (LABA)/long-acti...
The aim of this study was to assess the current evidence for long-acting β2-agonist (LABA)/long-acti...
The aim of this study was to assess the current evidence for long-acting β2-agonist (LABA)/long-acti...
Objectives: The aim of this study was to assess the current evidence for long-acting Β2-agonist (LAB...
Objectives: The aim of this study was to assess the current evidence for long-acting Β2-agonist (LAB...
The wide availability of long-acting muscarinic antagonist (LAMA)/long-acting β2-agonist (LABA) fixe...
The wide availability of long-acting muscarinic antagonist (LAMA)/long-acting β2-agonist (LABA) fixe...
The wide availability of long-acting muscarinic antagonist (LAMA)/long-acting β2-agonist (LABA) fixe...
The wide availability of long-acting muscarinic antagonist (LAMA)/long-acting β2-agonist (LABA) fixe...
Paola Rogliani,1 Luigino Calzetta,1 Fulvio Braido,2 Mario Cazzola,1 Enrico Clini,3 Girolamo Pelaia,4...
Inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA) combination commonly prescribed to treat ...
Objectives: To assess the current evidence for long-acting β2-agonist (LABA)/long-acting muscarinic ...
Objectives: To assess the current evidence for long-acting β2-agonist (LABA)/long-acting muscarinic ...
Objectives: The aim of this study was to assess the current evidence for long-acting \u3922-agonist ...
The aim of this study was to assess the current evidence for long-acting β2-agonist (LABA)/long-acti...
The aim of this study was to assess the current evidence for long-acting β2-agonist (LABA)/long-acti...
The aim of this study was to assess the current evidence for long-acting β2-agonist (LABA)/long-acti...
The aim of this study was to assess the current evidence for long-acting β2-agonist (LABA)/long-acti...
Objectives: The aim of this study was to assess the current evidence for long-acting Β2-agonist (LAB...
Objectives: The aim of this study was to assess the current evidence for long-acting Β2-agonist (LAB...
The wide availability of long-acting muscarinic antagonist (LAMA)/long-acting β2-agonist (LABA) fixe...
The wide availability of long-acting muscarinic antagonist (LAMA)/long-acting β2-agonist (LABA) fixe...
The wide availability of long-acting muscarinic antagonist (LAMA)/long-acting β2-agonist (LABA) fixe...
The wide availability of long-acting muscarinic antagonist (LAMA)/long-acting β2-agonist (LABA) fixe...
Paola Rogliani,1 Luigino Calzetta,1 Fulvio Braido,2 Mario Cazzola,1 Enrico Clini,3 Girolamo Pelaia,4...
Inhaled corticosteroid (ICS)/long-acting β2-agonist (LABA) combination commonly prescribed to treat ...
Objectives: To assess the current evidence for long-acting β2-agonist (LABA)/long-acting muscarinic ...
Objectives: To assess the current evidence for long-acting β2-agonist (LABA)/long-acting muscarinic ...
Objectives: The aim of this study was to assess the current evidence for long-acting \u3922-agonist ...
DOI
Add to ORKG